Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2011

View Archived Issues

Phase II trial evaluates anakinra in patients with subarachnoid hemorrhage

Phase III data show benefits of azilsartan medoxomil potassium/chlorthalidone in hypertension

ATROSAB reduces disease symptoms in monkeys with arthritis

Phase II data presented on AZD-9668 in cystic fibrosis

Phase I trial evaluates ciprofloxacin dry powder inhaler in COPD

GSK claims new bromodomain-containing protein inhibitors

Novel lactam tachykinin receptor antagonists presented

New Toll-like receptor 7 agonists disclosed by IRM

Piramal Life Sciences discloses novel imidazopyridines

Merck KGaA patents new TGF-beta receptor type-1 inhibitors

Generex enters agreement to license RapidMist technology to Amarantus BioSciences

EMA accepts Pfizer's regulatory filing for axitinib in renal cell carcinoma

FDA grants priority review to Alexion's Soliris sBLA for atypical hemolytic uremic syndrome

D-Pharm forms agreement with Jiangsu Nhwa Pharmaceutical for DP-VPA in China

FDA clears Fujirebio Diagnostics' CYFRA 21-1 assay for monitoring lung cancer

Health Canada approves new indication for Gardasil

EMA to review Gentium's MAA for defibrotide under accelerated assessment

AcelRx receives U.S. army grant for phase II development of ARX-04 for acute pain

CrystalGenomics begins phase IIb trial of CG-100649 in osteoarthritis

COMP issues opinion on orphan drug of CYT-387 in myelofibrosis

European approval for Yellox as therapy for postoperative ocular inflammation

Nuvilex reports encouraging phase II data on new treatment for pancreatic cancer

Adaptimmune begins phase I/II trial of T-cell therapy in multiple myeloma

HIV-1 vaccine candidate rVSVIN-N4CT9-Gag1 enters phase I trial

Ferring and Kyowa Hakko Kirin conclude copromotion agreement for desmopressin tablets in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...